Teligent Cash Flow from Operating Activities 2010-2021 | TLGT
Teligent cash flow from operating activities from 2010 to 2021. Cash flow from operating activities can be defined as a company's cash flows from operations.
Teligent Annual Cash Flow Ops
(Millions of US $) |
| 2020 |
$-17 |
| 2019 |
$-18 |
| 2018 |
$-13 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$-16 |
| 2014 |
$-4 |
| 2013 |
$-1 |
| 2012 |
$-2 |
| 2011 |
$-2 |
| 2010 |
$-3 |
| 2009 |
$-4 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
